Analyst consensus rating
Emergent BioSolutions Analyst Rating: Buy
Direct answer
Emergent BioSolutions's consensus rating is Buy.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.00.
Forecast evidence checked November 8, 2026.
Get free Emergent BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.06
- Average price target
- $10.00
- High price target
- $10.00
- Low price target
- $10.00
- Low target gap
- +65%
- Target upside
- +65%
- High target gap
- +65%
- Target range width
- 0%
- Consensus rating
- Buy
- Analysts
- 2
- Evidence date
- November 8, 2026
- Valid through
- November 15, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Emergent BioSolutions?
Emergent BioSolutions has a verified Buy consensus. The same dataset has an average price target of $10.00.
How far are Emergent BioSolutions's low and high targets from the recorded price?
The low target implies +65%, while the high target implies +65%.
How many analysts are included in Emergent BioSolutions's consensus?
The verified consensus includes 2 analysts.
How is Emergent BioSolutions's target upside or downside calculated?
The average target of $10.00 is divided by the recorded price of $6.06, then one is subtracted to produce +65%. This does not guarantee a future return.
When was Emergent BioSolutions's analyst forecast verified?
The data was verified on 2026-11-08. The dataset is valid through 2026-11-15.